Your browser doesn't support javascript.
loading
Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL-Induced B-Cell Acute Lymphoblastic Leukemia.
Yang, Linyu; Qiu, Qiang; Tang, Minghai; Wang, Fang; Yi, Yuyao; Yi, Dongni; Yang, Zhuang; Zhu, Zejiang; Zheng, Shoujun; Yang, Jianhong; Pei, Heying; Zheng, Li; Chen, Yong; Gou, Liping; Luo, Liya; Deng, Xing; Ye, Haoyu; Hu, Yiguo; Niu, Ting; Chen, Lijuan.
Afiliação
  • Yang L; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Qiu Q; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Tang M; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Wang F; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Yi Y; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
  • Yi D; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
  • Yang Z; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Zhu Z; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Zheng S; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Yang J; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Pei H; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Zheng L; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Chen Y; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Gou L; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Luo L; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Deng X; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Ye H; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China.
  • Hu Y; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China. chenlijuan125@163.com tingniu@sina.com huyiguo@scu.edu.cn.
  • Niu T; State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, China. chenlijuan125@163.com tingniu@sina.com huyiguo@scu.edu.cn.
  • Chen L; Department of Hematology and Research Laboratory of Hematology, West China Hospital of Sichuan University, Chengdu, China.
Clin Cancer Res ; 25(24): 7527-7539, 2019 12 15.
Article em En | MEDLINE | ID: mdl-31439580
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão bcr-abl / Apoptose / Mesilatos / Resistencia a Medicamentos Antineoplásicos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Inibidores de Histona Desacetilases / Histona Desacetilases Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Fusão bcr-abl / Apoptose / Mesilatos / Resistencia a Medicamentos Antineoplásicos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Inibidores de Histona Desacetilases / Histona Desacetilases Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article